SOC Telemed (SOC Telemed) Operating Income : $ Mil (TTM As of Dec. 2021)

View and export this data going back to 2020. Start your Free Trial

What is SOC Telemed Operating Income?

SOC Telemed's Operating Income for the six months ended in Dec. 2021 was $-56.26 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. SOC Telemed's Operating Income for the six months ended in Dec. 2021 was $-56.26 Mil. SOC Telemed's Revenue for the six months ended in Dec. 2021 was $94.44 Mil. Therefore, SOC Telemed's Operating Margin % for the quarter that ended in Dec. 2021 was -59.57%.

SOC Telemed's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. SOC Telemed's annualized ROC % for the quarter that ended in Dec. 2021 was -41.71%. SOC Telemed's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2021 was -779.44%.

SOC Telemed Operating Income Historical Data

The historical data trend for SOC Telemed's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SOC Telemed Operating Income Chart

SOC Telemed Annual Data

Trend

Dec19

Dec20

Dec21

Operating Income

-9.94

-41.83

-56.26

SOC Telemed Semi-Annual Data
	Dec19	Dec20	Dec21
Operating Income	-9.94	-41.83	-56.26

SOC Telemed Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Operating Income for the trailing twelve months (TTM) ended in Dec. 2021 was $ Mil.

SOC Telemed (NAS:TLMD) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

SOC Telemed's annualized ROC % for the quarter that ended in Dec. 2021 is calculated as:

	ROC % (Q: Dec. 2021 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2020 )	+	Invested Capital (Q: Dec. 2021 ))	/ count )
=	-56.255 * ( 1 - 0.3% )	/	( (43.903	+	225.06)	/ 2 )
=	-56.086235	/	134.4815
=	-41.71 %

where

	Invested Capital		(Q: Dec. 2020 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	84.939	-	7.892	-	( 38.754	-	max(0, 15.94	-	49.084	+	38.754	))
=	43.903

	Invested Capital		(Q: Dec. 2021 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	274.225	-	10.305	-	( 38.86	-	max(0, 18.178	-	60.317	+	38.86	))
=	225.06

Note: The Operating Income data used here is one times the annual (Dec. 2021) data.

2. Joel Greenblatt's definition of Return on Capital:

SOC Telemed's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2021 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2021 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2020		Q: Dec. 2021
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-41.665	/	( ( (4.092 + max(-5.61, 0))	+	(3.295 + max(3.304, 0)) )	/	2 )
=	-41.665	/	( ( 4.092	+	6.599 )	/	2 )
=	-41.665	/	5.3455
=	-779.44 %

where Working Capital is:

	Working Capital		(Q: Dec. 2020 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(8.721	+	0	+	1.609)	-	(7.892	+	0.61	+	7.438)
=	-5.61

	Working Capital		(Q: Dec. 2021 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(17.837	+	0.754	+	2.866)	-	(10.305	+	0.52	+	7.328)
=	3.304

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Dec. 2021) EBIT data.

3. Operating Income is also linked to Operating Margin %:

SOC Telemed's Operating Margin % for the quarter that ended in Dec. 2021 is calculated as:

Operating Margin %	=	Operating Income (Q: Dec. 2021 )	/	Revenue (Q: Dec. 2021 )
	=	-56.255	/	94.442
	=	-59.57 %

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.

Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.

SOC Telemed Operating Income Related Terms

Thank you for viewing the detailed overview of SOC Telemed's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.

SOC Telemed (SOC Telemed) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SOC Telemed Inc (NAS:TLMD) » Definitions » Operating Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

1768 Business Center Drive, Suite 100, Reston, VA, USA, 20190

Website

https://www.soctelemed.com

SOC Telemed Inc is a provider of acute care telemedicine services and technology to U.S. hospitals and healthcare systems based on number of clients. It provides technology enabled clinical solutions which include acute teleNeurology, telePsychiatry, and teleICU, and telePulmonology service. It supports specialty care, providing time-sensitive specialty care when patients are vulnerable and may not otherwise have access. Its solution was developed to support complex workflows in the acute care setting by integrating cloud-based software platform, Telemed IQ, with a panel of patient advocates and a network of clinical specialists to create a seamless, acute telemedicine solution.

Executives

Robert Jason Hallock	officer: Chief Medical Officer	C/O SOC TELEMED 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
David R. Fletcher	officer: Interim CFO	C/O SOC TELEMED, INC., 1768 BUSINESS CENTER DRIVE, SUITE 100, RESTON VA 20190
David Mikula	officer: Chief Operating Officer	C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Gyasi C. Chisley	director	C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Christopher M. Gallagher	director	C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Steven J Shulman	director	1564 NE EXPRESSWAY, ATTN: BJ PURCELL, ATLANTA GA 30329
Christopher K Knibb	officer: Chief Financial Officer	C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Warburg Pincus Partners Ii, L.p.	director, 10 percent owner	450 LEXINGTON AVENUE, C/O WARBURG PINCUS LLC, NEW YORK NY 10017
Anne Mcgeorge	director	C/O MAGENTA THERAPEUTICS, INC., 100 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE MA 02139
Wpxi Finance, Lp	director, 10 percent owner	C/O WARBURG PINCUS LLC, 450 LEXINGTON AVENUE, NEW YORK NY 10017
Wpxi Gp, L.p.	director, 10 percent owner	C/O WARBURG PINCUS LLC, 450 LEXINGTON AVE, NEW YORK NY 10017
Warburg Pincus & Co.	director, 10 percent owner	450 LEXINGTON AVENUE, NEW YORK, NY NY 100173147
Amr Kronfol	director	C/O WARBURG PINCUS LLC, 450 LEXINGTON AVE, NEW YORK NY 10017
Joseph P Greskoviak	director	C/O SOC TELEMED, INC. 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190
Sean Banerjee	officer: Chief Technology Officer	C/O SOC TELEMED 1768 BUSINESS CENTER DRIVE, SUITE 100 RESTON VA 20190